Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

CoreAge Rx vs Edessa

Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Edessa a 68. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

CoreAge Rx

#1 · Grade A+ · Best Value

Est. first month

$99/mo

Save ~89% vs brand-name
Get this deal Full CoreAge Rx review →
VS

Edessa

#284 · Grade C · Watch List

Est. first month

$179 (semaglutide injection), month to month

Save ~87% vs brand-name
Get this deal Full Edessa review →

The verdict

Better value: CoreAge Rx

CoreAge Rx takes it on Value Score, 93 to 68 an est. $99/mo first month, with no teaser step-up baked in. Edessa isn't out of it: A six-month committer, or anyone willing to click past the homepage to the table with the real monthly rate.

CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealCoreAge RxEdessa
Value Score93 (A+)68 (C)
Est. first month$99/mo$179 (semaglutide injection), month to month
Save vs brand-name~89%~87%
Semaglutide$99/mo$179/mo month-to-month injectable ($135 only on a 6-month prepay)
Tirzepatide$149/mo$239/mo month-to-month ($209 only on a 6-month prepay)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

88
Lowest Real Price
74
CoreAge Rx: 88. Edessa: 74.
98
No Teaser-Rate Bait
48
CoreAge Rx: 98. Edessa: 48.
98
Nationwide Availability
64
CoreAge Rx: 98. Edessa: 64.
95
Both Molecules
82
CoreAge Rx: 95. Edessa: 82.
95
Easy Cancellation
68
CoreAge Rx: 95. Edessa: 68.
84
Reputation
70
CoreAge Rx: 84. Edessa: 70.

CoreAge Rx

The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.

Why it's a deal

  • Flat, all-in monthly price with no intro-rate step-ups after month one
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states
  • Straightforward, low-friction cancellation — no lock-in

The fine print

  • Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner

Edessa

Clean three-rung tables one click in, behind a homepage whose cheapest number is both a prepay and a different drug.

Why it's a deal

  • Each product page carries a plain three-rung table, so the commitment behind every figure is visible
  • "Same price, every dose" is printed on each product page
  • Names its operating entity and a full street address in Las Vegas, Nevada
  • All-inclusive — consultation, medication, free expedited shipping, ongoing check-ins and 24/7 support — and HSA and FSA eligible

The fine print

  • The homepage leads with a six-month prepay on a different drug from the one a tirzepatide reader wants
  • All three homepage cards quote the six-month rung
  • Its Terms give two corporate forms for the same company in one clause — "Edessa Group, LLC, a Nevada corporation"
  • "Join 100,000+ successful GLP-1 patients" carries no source, and the money-back guarantee's terms are on no marketing page
Get the CoreAge Rx deal Get the Edessa deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Edessa.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.